Hospira LifeCare PCA Infusion System
Vulnerability Description
The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.
Impact Analysis
Refer to official advisory for detailed impact metrics.
Remediation
Ensure systems are updated to the latest vendor-supplied patch levels.
Am I Vulnerable?
Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2014-5406
Credits & Attribution
The following person or organization is credited with identifying this vulnerability, as recorded in the NVD database:
- Billy Rios
References
- https://www.cisa.gov/news-events/ics-advisories/icsa-15-125-01
- http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm446809.htm
- https://xs-sniper.com/blog/2015/06/08/hospira-plum-a-infusion-pump-vulnerabilities/
- https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2015/icsa-15-125-01.json
More from Hospira
View All →Affected Vendor
Hospira
View all reports →